AntiCancer Sues Cellsight Over Tumor Detection IP
Pioneering research outfit AntiCancer Inc. is alleging rival Cellsight Technologies Inc. has infringed patents on the use of fluorescence to track tumors and violated California competition law....To view the full article, register now.
Already a subscriber? Click here to view full article